Stock Scorecard
Stock Summary for Stoke Therapeutics Inc (STOK) - $12.07 as of 12/3/2024 10:57:16 AM EST
Total Score
9 out of 30
Safety Score
32 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for STOK
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for STOK
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for STOK
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for STOK
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for STOK (32 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for STOK
Financial Details for STOK
Company Overview |
|
|---|---|
| Ticker | STOK |
| Company Name | Stoke Therapeutics Inc |
| Country | USA |
| Description | Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops new antisense oligonucleotide (ASO) drugs to treat the underlying causes of serious genetic diseases in the United States. The company is headquartered in Bedford, Massachusetts. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 12.07 |
| Price 4 Years Ago | 61.93 |
| Last Day Price Updated | 12/3/2024 10:57:16 AM EST |
| Last Day Volume | 280,598 |
| Average Daily Volume | 433,057 |
| 52-Week High | 17.58 |
| 52-Week Low | 3.78 |
| Last Price to 52 Week Low | 219.31% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 22.17 |
| Sector PE | 42.52 |
| 5-Year Average PE | -12.79 |
| Free Cash Flow Ratio | 2.67 |
| Industry Free Cash Flow Ratio | 12.01 |
| Sector Free Cash Flow Ratio | 28.39 |
| Current Ratio Most Recent Quarter | 5.09 |
| Total Cash Per Share | 4.52 |
| Book Value Per Share Most Recent Quarter | 4.38 |
| Price to Book Ratio | 2.76 |
| Industry Price to Book Ratio | 5.02 |
| Sector Price to Book Ratio | 20.73 |
| Price to Sales Ratio Twelve Trailing Months | 38.31 |
| Industry Price to Sales Ratio Twelve Trailing Months | 82.55 |
| Sector Price to Sales Ratio Twelve Trailing Months | 24.67 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 52,967,000 |
| Market Capitalization | 639,311,690 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -3.59% |
| Reported EPS 12 Trailing Months | -2.08 |
| Reported EPS Past Year | -1.50 |
| Reported EPS Prior Year | -2.37 |
| Net Income Twelve Trailing Months | -105,457,000 |
| Net Income Past Year | -104,699,000 |
| Net Income Prior Year | -101,067,000 |
| Quarterly Revenue Growth YOY | 47.90% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | -6.13 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 239,200,000 |
| Total Cash Past Year | 201,394,000 |
| Total Cash Prior Year | 229,595,000 |
| Net Cash Position Most Recent Quarter | 239,200,000 |
| Net Cash Position Past Year | 201,394,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 159,565,000 |
| Total Stockholder Equity Prior Year | 184,849,000 |
| Total Stockholder Equity Most Recent Quarter | 232,113,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -84,697,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.60 |
| Free Cash Flow Past Year | -82,683,000 |
| Free Cash Flow Prior Year | -35,828,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.30 |
| MACD Signal | -0.22 |
| 20-Day Bollinger Lower Band | 10.75 |
| 20-Day Bollinger Middle Band | 13.30 |
| 20-Day Bollinger Upper Band | 15.85 |
| Beta | 0.95 |
| RSI | 43.86 |
| 50-Day SMA | 11.24 |
| 150-Day SMA | 11.30 |
| 200-Day SMA | 16.67 |
System |
|
| Modified | 11/30/2024 1:12:32 PM EST |